Dr. Steven Frank is the Chairman of the Breakthrough Chronic Care Scientific Advisory Board. A leading specialist Proton-Heavy-Ion Therapy.

“We believe Breakthrough Chronic Care’s superior disease management model for average Americans can be disruptive to the trillion-dollar chronic care industry. The cost-saving benefits can be significant. Studies show that patients with several different chronic illnesses may have higher cancer rates than the general public. We are addressing this health issue by improving the doctor-patient relationship and providing solutions to strengthen the immune system.”

Steven J. Frank, MD

Medical Director, Director of Advanced Technologies

MD Anderson Cancer Center.

Dr. Frank is an endowed tenured professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center, the Medical Director of MD Anderson’s Proton Therapy Center, and the leader of both the Proton Therapy Program for head and neck cancer and the Prostate Brachytherapy Program. Dr. Frank also serves the Division as Director of Advanced Technologies in Radiation Oncology; he is amongst the first, if not the first, to use Intensity-Modulated Proton Therapy (IMPT) to treat head and neck tumors. Dr. Frank is the Principal Investigator of an NIH/NCI-sponsored Phase II/III randomized trial in oropharyngeal cancer that compares outcomes after chemoradiation given by IMRT versus IMPT. 

 

His other major clinical research accomplishment includes the successful accrual of 300 patients in a Phase II protocol for prostate cancer. Dr. Frank’s expertise in MRI radiotherapy has led to the development and FDA approval of a novel positive-contrast implantable marker for use in MRI-guided prostate brachytherapy. As the founder of the company, C4 Imaging, Dr. Frank has developed the MRI marker technology at MD Anderson, currently holds 31 national and international patents and has continued MRI-Assisted Radiosurgery (MARS) at MD Anderson for the treatment of prostate cancer. 

Dr. Thomas Buchholz is the Vice Chairman of the Breakthrough Chronic Care Scientific Advisory Board. He is a leading breast cancer specialist.

“I believe that Breakthrough Chronic Care is at the forefront of redefining optimum care for chronic care patients. We are committed to improving the doctor-patient relationship and strengthening the immune system. Both are paramount. Patients with several different chronic illnesses may have higher cancer rates than the general population. We are addressing this with our innovative Breakthrough Immune Support System.”

Thomas A Buchholz, MD

F.A.C.R., F.A.S.T.R.O

Medical Director, Scripps MD Anderson Cancer Center

Dr. Buchholz is a Professor, Executive Vice President and Physician-in-Chief at The University of Texas MD Anderson Cancer Center. He holds the Hubert L. Stringer Distinguished Chair in Oncology in Honor of Sue Gribble Stringer. In his role as Physician-in-Chief, Dr. Buchholz is responsible for the clinical faculty and operating of MD Anderson’s Houston hospital and ambulatory clinics. His academic interests focus on clinical and translational research in breast cancer and radiation oncology. 

 

An acclaimed researcher and scholar. He is now the Medical Director at Scripps MD Anderson Cancer Center, a clinically integrated cancer care facility in San Diego, California.

Dr. Chris Suhar, Medical Director at Scripps Research Institute Joins the Scientific Advisory Board at Breakthrough Chronic Care. 

“Breakthrough Chronic Care is redefining optimum chronic care for average Americans. The Breakthrough Immune Support System can be extremely helpful in strengthening the immune system. I look forward to designing our MEGA MEALS, and all supporting products, to maximize a healthy immune system. The short-term and long-term benefits to the chronic care industry can be game-changing.”

Christopher Suhar MD

Medical Director for Integrative Medicine, Scripps Center for Cardiology Fellowship Program

Christopher Suhar, MD, is an integrative cardiologist with expertise in general cardiology and integrative medicine. He also has sub-specialty training in echocardiography and nuclear cardiology. In addition to utilizing conventional medicine, Dr. Suhar uses evidence-based alternative therapies to treat patients with coronary artery disease, irregular heartbeat, high cholesterol, and hypertension. He also believes in prevention, working with patients to identify potential risk factors, including family history, to prevent cardiovascular disease.

 

Dr. Suhar holds Board Certifications with the National Board of Echocardiography, Adult Comprehensive Echocardiography, American Board of Internal Medicine, Cardiovascular Disease, and the Certification Board of Nuclear Cardiology. In addition to his clinical practice, he conducts research on the outcomes and long-term benefits of integrative medicine and lifestyle changes in people with cardiovascular disease. He is also involved in researching the benefits of new technologies for patients in cardiac rehabilitation.

Eric Tait, M.D., MBA, Physician Business Expert becomes the V.P. of Concierge Chronic Care Doctor Development of Breakthrough Chronic Care.

“Our Concierge Chronic Care Doctor opportunity greatly benefits independent physicians both financially and by improving their lifestyle. They can significantly increase their income while being empowered to provide closer doctor-patient relationships. The Breakthrough Chronic Care model is very innovative. Primary Care Doctors nationwide will eagerly join our team.”

Eric Tait, MD., MBA 

Leading Physician Business Expert

Eric Tait is an Investment Fund Manager with Vernonville Asset Management LLC, a private investment firm that helps investors attain or maintain financial independence through the use of alternative assets. Eric is also a Physician who is board-certified in Internal Medicine and is Founder of The Physician’s Road a Physician Services Firm dedicated to helping physicians and other medical professionals create their lives in medicine on their own terms by providing resources in 5 area – Wealth Accumulation, Practice Enhancement, Improved Health, Enhanced Relationships, and Personal Development. 

 

Dr. Tait attended Morehouse College in Atlanta, GA, and graduated cum laude with a Bachelors of Science degree in Biology.  At Morehouse Eric was very involved in the Health Careers Society and mentoring elementary school children in math and science.

 

After college, Dr. Tait relocated to Houston to attend Rice University’s Jesse H. Jones School of Management and Baylor College of Medicine where he received his dual-degree M.D./MBA. During Dr. Tait’s tenure at Rice, he worked for Aetna Healthcare as special assistant to the Senior Network Medical Director for the Eastern Pennsylvania, Southern New Jersey, and Delaware region.  Eric graduated from Rice University with an MBA in Healthcare Management and a concentration in entrepreneurship.  

Margaret Handmaker 

Executive Consultant

Margaret Handmaker, Mercer Consultants former Worldwide Partner and Director of North American Operations joins the Board of Directors of Breakthrough Chronic Care.

“ I have worked directly with the CEOs and Boards of several Fortune 500 companies, including healthcare companies, attempting to optimize their healthcare investment. I believe Breakthrough Chronic Care is addressing a major healthcare issue that is a “black hole” in disease management and unnecessary costs for chronically ill patients. Unfortunately, many have high-deductible medical insurance which results in fragmented care with poor disease management. The Breakthrough Chronic Care model could have a significant impact to solve this trillion-dollar problem. ”

Margaret Handmaker was responsible for several Fortune 500 Companies, including CVS (NYSE), Tenet (NYSE),  Da Vita (NYSE), Blue Cross Blue Shield of Illinois, Community Health Systems (NYSE), Yum! Brands, JP Morgan Chase, Shell Oil, Sara Lee, and Rider Systems. She spent almost 30 years in management consulting, first at Booz Allen Hamilton and then at Mercer, Inc. She was responsible for Mercer Consultant’s North American Operations, representing over two billion in annual billing. 

 

Margaret Handmaker serves as the vice-chair of the Louisville Board of Health. She has also served as Secretary of Revenue for the Commonwealth of Kentucky and the Governor’s Executive Cabinet, and on the Board of the Downtown Development Corporation as Executive Director.

 

She provides consulting and leadership services to Bloomberg Philanthropies and partner organizations. Ms. Handmaker was the Chief of Economic Development for Louisville, KY and led the city’s innovation team, funded by Bloomberg Philanthropies. 

Terry Lord, Former Section Head, U.S. Dept. of Justice, becomes Sr. V.P. of Corporate Development of Breakthrough Chronic Care.

“Our chronic care patients are sincerely excited about our innovative approach to meeting their individual needs. They appreciate the security of having a close doctor-patient relationship with a doctor committed to their well-being on many levels. Additionally, chronic care patients have significantly higher cancer rates than the general population. We work closely with the Cancer Terminator Foundation to bring the latest advances in cancer treatment for our patients.”

Terry Lord

Senior V.P. of Corporate Development, Breakthrough Chronic Care

Mr. Lord retired from the US Department of Justice (DOJ) after serving as a prosecutor in the Criminal Division for almost thirty years.  He began as a Special Attorney in the Organized Crime and Racketeering Section in 1970 serving on Strike Forces in Chicago, Los Angeles, and Las Vegas.  The Assistant Attorney General (AAG) for the Criminal Division named him the Chief of the Las Vegas Strike Force in 1987.  Selected by the American Political Science Association in 1990 to be a Congressional Fellow, Lord spent a year in the US Senate as a Legislative Assistant to Senator Joe Lieberman (D-I-Conn).  He aided the Senator with legislative hearings in the Governmental Affairs Committee chaired by the late Senator John Glenn (D-Ohio) and Senate floor debate on a variety of bills.  

 

Upon completion of the one year Senate Fellowship, Lord returned to the DOJ Criminal Division as the Principal Deputy Chief of the General Litigation and Legal Advice Section (GLLAS).  This section, one of the largest in the Division at the time, prosecuted cases involving immigration and customs fraud, industrial health and safety criminal violations, bribery and graft not involving official corruption, Indian affairs, and many other federal offenses.  From 1994 to 1996, Lord was the Acting Chief of GLLAS. Lord completed his DOJ career as the Acting Regional Director for Central Europe, OPDAT, working in Washington, DC from 2003-2004.  He supervised and directed RLA programs in eleven countries, although a majority of the efforts focused on the Balkans. Lord now lives in Houston, Texas.  He is a 50-year member of the State Bar of  Texas, Vietnam War veteran and educated at Southern Methodist University (BA-1963) and the University of Texas School of Law (JD-1966).

Jack and Barbara Nicklaus become an active ‘SpokesCouple’ for The Cancer Terminator Foundation

“We are excited to join Dr. Frank, Dr. Hug and the remarkable scientists at the Cancer Terminator Foundation who have helped pioneer this groundbreaking cancer treatment for children and adults. We look forward to working with Breakthrough Chronic Care introducing it to America.”

Nicklaus holds the record for PGA major championships with a total 18. He played on six Ryder Cup teams, captained the team twice and the Presidents Cup team four times, and topped the PGA Tour money list and scoring average eight times each. For 24 straight seasons, from 1960 to 1983 inclusive, he made at least one top ten finish in a major championship, and this is a record.

 

His likeness was featured on a special commemorative issue five-pound note issued by the Royal Bank of Scotland, making him the first living person outside the Royal Family to appear on a British banknote. In 2001, Nicklaus was honored with the “Lombardi Award of Excellence” from the Vince Lombardi Cancer Foundation. The award was created to honor Coach Lombardi’s legacy and is awarded annually to an individual who exemplifies the spirit of the Coach.

 

Along with Annika Sörenstam, Nicklaus was named a Global Ambassador for the International Golf Federation in 2008 and was instrumental in bringing golf to the Olympics for the 2016 and 2020 games. On May 19, 2014, the United States House of Representatives awarded Nicklaus the Congressional Gold Medal “in recognition of his service to the nation in promoting excellence and good sportsmanship”. 

Retired Brigadier General Donald Bolduc is an ‘Ambassador’ for the Veterans Advancement Department of Breakthrough Chronic Care.

“I applaud Breakthrough Chronic Care and the Cancer Terminator Foundation for their innovative efforts in helping our Veterans get state-of-the-art treatments. I suffered from PTSI for several years. Then I discovered Stellate Ganglion Block (SGB) and it changed my life for the better immediately. Every Veteran diagnosed with PTSI should have access to SGB. I believe that the Concierge Chronic Care Doctor, the Breakthrough Immune Support System, and the Cancer Terminator will be groundbreaking for our Veteran community.”

Retired Brigadier General Donald Bolduc 

Commander of Special Operations 

Command-Africa in the U.S. Army

Brigadier General Don Bolduc is the highest-ranking officer ever to acknowledge suffering fro PTSD. He is an American hero. During his 36 year career with the US Army, he received two awards for valor, five Bronze Star Medals, and two Purple Hearts. He led one of the first groups in Afghanistan after the 9/11 attacks, riding on horseback to take control of the southern Afghan region from the Taliban. He was also one of the few survivors of both a helicopter crash and a 2,000-pound bomb that inadvertently targeted on his position by friendly fire. His services then included assignments as Commander, Combined Joint Special Operations Component Commander in Afghanistan, as Deputy Director for US Africa Command (USAFRICOM) and as Special Operations Command-Africa (COMSOCAFRICA). 

 

He has been awarded the Defense Service Medal, the Defense Superior Service Medal, Legion of Merit, Army Commendation Medal with Valor Device and numerous awards from our allies. 

 

After returning home to New Hampshire, General Bolduc has been a tireless advocate to combat the stigma around and treatment of post-traumatic stress (PTS). He was one of the few senior military officers and the only active-duty general officer on record at the time to discuss his own struggles with PTS. His leadership on this issue and others earned him the nickname of “Captain America” and “Everyone’s General” by his fellow officers and soldiers. 

Rick Barry, NBA Hall of Fame, Joins Breakthrough Chronic Care as V.P. Chief ‘Networking’ Officer.

“I am excited about joining the team. Truly great organizations. I understand from personal experience the emotional and financial stress a chronic illness can create for a family. I have been blessed with a lifetime of great friendships. I am enthusiastic to introduce Breakthrough Chronic Care and the Cancer Terminator Foundation to many of America’s leading business leaders and sports celebrities. Virtually everyone we speak to sincerely wants to get involved.”

About Rick Barry

Only player in basketball history to lead the NBA, ABA, and NCAA in scoring in individual seasons. Elected to NBA’s All-Time Best 50 Players. He led the Golden State Warriors to the NBA World Champion. MVP of finals. 2 time All American at the University of Miami. He graduated Kappa Sigma. 

 

Barry was one of the first basketball professionals to make a successful transition to TV and radio broadcasting. Rick and Bill Russell were the broadcasting team for TBS Sports. Barry co-hosts a basketball show on Sirius Satellite Radio. His son Brent won the NBA Championship with San Antonio Spurs becoming the second father-son duo to both win the NBA Championship as players. He is an avid golfer who was the ReMax Golf Long Drive Senior Champion... 301 yards.

Oren Cahlon, MD. Physician-in-Chief, Radiation Oncology, Sloan Kettering Cancer Center joins the Cancer Terminator Foundation Scientific Advisory Board.

“ Memorial Sloan Kettering has been at the forefront of cancer treatments. The Cancer Terminator Foundation and Heavy-Ion therapy is exactly that. Dr. Hug, Dr. Frank, and our esteemed Scientific Advisory Board can accomplish significant advances in the successful treatment of late-stage cancers that were not available before. Breakthrough Chronic Care has been instrumental in our development. ”

Oren Cahlon, MD

Associate Deputy Physician-in-Chief, Regional Care Network; Vice-Chair, Department of Radiation Oncology, Sloan Kettering Cancer Center.

Oren Cahlon, MD, is a board-certified radiation oncologist whose clinical practice is primarily focused on breast cancer. As part of a multi-disciplinary team of breast cancer experts, he works to identify the optimal treatment approach for each patient. At Memorial Sloan Kettering, they use the most modern radiation techniques, including prone treatment, deep inspiratory breath-hold, partial breast irradiation, intensity-modulated radiation therapy (IMRT), and proton therapy to deliver the most precise form of radiation. He and his colleagues have great expertise in using all the most modern forms of radiation, and we tailor the optimal technique to each individual patient.

 

He also specializes in the use of proton therapy to treat a variety of tumors that are difficult to treat with traditional forms of radiation, such as pediatric tumors, head and neck cancer, and lung cancer. Currently, this unique technology is available at only 12 centers in the United States. Dr. Cahlon, along with other radiation oncologists from Memorial Sloan Kettering, treat select patients with proton beam therapy at the ProCure Proton Therapy Center in Somerset, New Jersey.

Bhadrasain Vikram, MD. Chief of Clinical Radiation Oncology at the National Cancer Institute joins the Cancer Terminator Foundation Scientific Advisory Board.

“The National Cancer Institute believes Heavy-Ion is the next generation in curing several cancers that are untreatable today. I look forward to working with Dr. Frank and Dr. Hug in providing it to as many patients as possible. Our mission is critical and the Cancer Terminator Foundation will play a vital role. We appreciate Breakthrough Chronic Care for helping to make it a reality.”

Bhadrasain Vikram, MD

Chief of the Clinical Radiation Oncology Branch at the NCI.

Dr. Vikram received his medical degree from the University of Delhi and trained in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York City. He subsequently served on the faculties of Memorial Sloan-Kettering, Cornell University Medical College and Mount Sinai School of Medicine. He has authored over 150 scientific publications and was listed as among the 1000 ‘Best Doctors in America’ by American Health magazine, a Reader’s Digest publication. From 2002-2006 he worked at the International Atomic Energy Agency of the United Nations in Vienna, Austria, helping to establish or upgrade cancer therapy facilities in about 100 low and middle-income countries, and founded the Program of Action for Cancer Therapy (PACT). In 2005 he shared in the Nobel Peace Prize awarded to the IAEA whose contribution to global cancer control was cited by the Nobel committee.

 

Since 2006 he has served as Chief of the Clinical Radiation Oncology Branch at the NCI, overseeing a portfolio of clinical research grants within the Radiation Research Program as well as assisting the Cancer Therapy Evaluation Program and the Coordinating Center for Clinical Trials with NCI’s cooperative clinical trials groups program. He also continues his work on improving cancer prevention and control worldwide.

Richard Cantwell, PE, CEO of Global PTSI Foundation, becomes the Executive Director of the Veterans Advancement Department of Breakthrough Chronic Care. 

“We are proud that the Global PTSI Foundation is a pioneer in providing Veterans with PTSI the revolutionary treatment of Stellate Ganglion Block
(SGB)
. With the addition of Concierge Chronic Care Doctors, the Breakthrough Immune Support System, and advanced cancer treatments with the Cancer Terminator Foundation, our Veterans will be receiving world-class treatment.”

Richard D. Cantwell, PE

Chairman, Global PTSI Foundation

Richard Cantwell served 20 years with the U.S. Army Corps of Engineers, retiring in 1995 as a decorated combat veteran. As MACOM Engineer for the U.S. Army Special Operations Command (USASOC), he was responsible for the Planning, Master Planning, Programming, Budgeting and Execution of all related training and combat facilities. 

 

He also supervised the Long Range Planning, Environmental Assessment and Master Planning for the command, with responsibilities that included briefings and defending these programs before the U.S. Congress. From 1995-1999, Mr. Cantwell was a Managing Partner/Board Member of Odell Associates, Inc. serving as the Principal Liaison/Program Manager for Daily Progress between government staff of the United Arab Emirates (UAE) and USA Medical Centers, Specialists, Consultants, and Administrators, with Johns Hopkins Hospital and Partners Hospital (Massachusetts General). He currently serves as a representative of public and private industries as a specialist in subject matter, and Chairman of the Global PTSI Foundation.

Sean Mulvaney, M.D. Leading PTSD Specialist Joins the Scientific Advisory Board of Breakthrough Chronic Care.

“Our physicians at Breakthrough Chronic Care are the most experienced in the country in providing the Stellate Ganglion Block
(SGB)
procedure. We have learned over the last few years by performing thousands of procedures the most advanced techniques to maximize its effectiveness. I look forward in training and supporting physicians across the country to take advantage of our experience and optimize the positive impact of SGB for Breakthrough Chronic Care patients, Veterans and non-Veterans alike.”

Sean Mulvaney, MD

Fmr. US Navy SEAL Officer
and US Army Physician

Sean Mulvaney, MD, is an Associate Professor of Medicine at the Uniformed Services University in Bethesda, Maryland and is board certified in Sports Medicine and Pain Medicine. During his entire 31-year military career, he served our nation’s Special Operations community as both a Navy SEAL officer for 9 years and an Army physician for 22 years. He was the first Department of Defense physician to be credentialed in platelet-rich plasma and stem cell therapy for repair of musculoskeletal and spine injuries starting in 2008.  He is a pioneer in working with the Special Forces and Seal Team 6 for PTSD treatments.

 

He has done pioneering research in the use of stellate ganglion block to treat PTSD. He has an international reputation as an educator of other physicians and pioneered and published on ultrasound-guided techniques. His practice (Regenerative Orthopedics & Sports Medicine) is focused on the repair of musculoskeletal, nerve and spine injuries using regenerative medicine techniques with ultrasound and fluoroscopic guidance. 

Dr. Harald Paganetti. Director of Physics Research at Harvard Medical School, Joins the Cancer Terminator Foundation Scientific Advisory Board.

“I look forward to working with Dr. Frank, Dr. Hug, and the preeminent physicians and scientists on the Scientific Advisory Board of the Cancer Terminator Foundation. This is an esteemed group of experts coming together for a single cause. Bringing Heavy-Ion Therapy to the United States is a cancer cure that is ready now, but American patients have not had access. Breakthrough Chronic Care’s vision and support is appreciated.”

Harald Paganetti, PhD

Director of Physics Research, Massachusetts General Hospital, Professor of Radiation Oncology, Harvard Medical School

Dr. Harald Paganetti is the Director of Physics Research at the Department of Radiation Oncology at Massachusetts General Hospital and Professor of Radiation Oncology at Harvard Medical School, Boston, USA. He received his PhD in experimental nuclear physics in 1992 from the Rheinische- Friedrich-Wilhelms University in Bonn, Germany, and has been working on experimental as well as theoretical projects in radiation therapy research since 1994. He has authored and co-authored more than 250 peer-reviewed publications and has edited 2 books. He is renowned particularly for his work on proton therapy.

 

Dr. Paganetti has been awarded numerous research grants from the National Cancer Institute in the United States. He serves on several editorial boards and is a member of task-groups and committees for various associations, such as the American Society for Therapeutic Radiology and Oncology (ASTRO) and the American Association of Physicists

in Medicine (AAPM). He also serves on the National Council on Radiation Protection (NCRP) in the United States.

Dr. Robert L. Foote, M.D. Chairman of Radiation Oncology at the Mayo Clinic Joins the Cancer Terminator Foundation Scientific Advisory Board.

“Bringing Heavy-Ion Therapy to the United States is a significant advance in treating late-stage cancers. It is the next generation in treating several cancers that we have no dependable treatment today. I enthusiastically support sending children and Veterans to see Dr. Hug in Vienna, Austria for immediate treatment. I thank Breakthrough Chronic Care for its vision and continued support.”

Robert L. Foote, MD

Radiation Oncologist, 

Chair, Radiation Oncology, Mayo Clinic, Minnesota

Robert L. Foote, MD, is Senior Resident Associate - Division of Radiation Oncology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. He serves as Chair of the Mayo Clinic Cancer Center, Rochester Cancer Practice Committee and as Chair of the Executive Committee, Department of Radiation Oncology. He is Co-Chair of the Written and Oral Examination for Head/Neck/Skin, American Board of Radiology

 

He is an active member of the Children’s Research Center, the American Society for Radiation Oncology, the Business Advisory Group for Mayo Clinic Rochester Workgroups, and the NRG Oncology Head and Neck Steering Care Committee, as a Team Leader for 

Heavy Charged Particle Therapy, Department of Radiation Oncology, and others.

 

In 2016 Dr. Foote was awarded the Mayo Clinic Excellence in Leadership and the Mayo Clinic Distinguished Clinician Award. He was also awarded the Distinguished Service Award by the American Board of Radiology in 2012.

Michael P. Hagan, M.D., PhD. Chairman of Radiation Oncology at the Department of Veterans Affairs, Joins the Scientific Advisory Board for the Cancer Terminator Foundation.

“The VA in 2016 made bringing Heavy-Ion Therapy to our cancer patients one of our top priorities. We partnered with Stanford Medical School. The funding did not happen. The Cancer Terminator Foundation and Breakthrough Chronic Care have stepped in to make it happen. I look forward to working with the Scientific Advisory Board to make it possible. Providing Heavy-Ion Therapy immediately for Veterans and children with Dr. Hug in Vienna, Austria is going to save lives.”

Michael P. Hagan, MD, PhD

Radiation Oncology Specialist

Dr. Michael P. Hagan is a Radiation Oncology specialist in Richmond, Virginia. He attended and graduated from Baylor College Of Medicine in 1989, having over 30 years of diverse experience, especially in Radiation Oncology. He is affiliated with many hospitals including Medical College Of Virginia Hospitals. He has extensive laboratory research experience involving the effects of irradiation on biological systems. Department of Energy Research Fellow at the Argonne National Laboratory, Senior Investigator and Division Chief for Cellular Radiobiology at the AFRRI. He specializes in the treatment of genitourinary malignancies. He is the Study Chair for the Genitourinary Section of the Radiation Therapy Oncology Group. Principal interests are bladder cancer and the use of brachytherapy in the treatment of prostate cancer.

Dr. Quynh-Thu Le. Chair, Department of Radiation Oncology, Stanford University, Joins the Cancer Terminator Foundation Scientific Advisory Board. 

“There is no question that Heavy-Ion Therapy is a major advance for treating several cancers that our present technology cannot. Stanford has worked with the Department of Veterans Affairs to bring it to America with no success. The Cancer Terminator Foundation is changing this. The long-term goal of building several Heavy-Ion machines in the United States is clearly needed. Providing children and Veteran cancer patients immediate free treatment with Dr. Hug in Vienna, Austria is lifesaving. Breakthrough Chronic Care’s continual support in helping to create the Cancer Terminator Foundation is greatly appreciated.”

Quynh-Thu Le, MD

Chair, Department of Radiation Oncology, Stanford University

Quynh-Thu Le, MD received both her medical school and radiation oncology training at the University of California, San Francisco (UCSF). She then joined the Stanford faculty in 1997. She became the Chair of the Stanford Radiation Oncology Department in September 2011. She also holds the Katharine Dexter McCormick & Stanley Memorial Professorship at Stanford University. Her research focuses on translating laboratory findings to the clinic and vice versa in head and neck cancer (HNC), specifically in the area of tumor hypoxia and salivary gland stem cells. Her research is reflected in both her publications and grant funding. Hers was one of the first groups that identified circulating biomarkers for tumor hypoxia in HNC, leading to the application of some of these markers in clinical trials, testing hypoxia targeted strategies. 

 

On the clinical side, she has led multicenter phase II and III clinical trials, testing the addition of novel drugs as either radiosensitizer or radioprotector with chemoradiotherapy in HNC. Administratively, she is the Co-Director of the Radiation Biology Program of the Stanford Cancer Institute and the Chair of the Head and Neck Cancer Committee of the NRG Oncology Group, which is part of the NCI supported National Clinical Trial Network (NCTN), running large phase II-III studies for radiation in solid cancers. She serves on the editorial board of several cancer-related journals.

Dr. Quynh-Thu Le. Chair, Department of Radiation Oncology, Stanford University, Joins the Cancer Terminator Foundation Scientific Advisory Board. 

“There is no question that Heavy-Ion Therapy is a major advance for treating several cancers that our present technology cannot. Stanford has worked with the Department of Veterans Affairs to bring it to America with no success. The Cancer Terminator Foundation is changing this. The long-term goal of building several Heavy-Ion machines in the United States is clearly needed. Providing children and Veteran cancer patients immediate free treatment with Dr. Hug in Vienna, Austria is lifesaving. Breakthrough Chronic Care’s continual support in helping to create the Cancer Terminator Foundation is greatly appreciated.”

Quynh-Thu Le, MD received both her medical school and radiation oncology training at the University of California, San Francisco (UCSF). She then joined the Stanford faculty in 1997. She became the Chair of the Stanford Radiation Oncology Department in September 2011. She also holds the Katharine Dexter McCormick & Stanley Memorial Professorship at Stanford University. Her research focuses on translating laboratory findings to the clinic and vice versa in head and neck cancer (HNC), specifically in the area of tumor hypoxia and salivary gland stem cells. Her research is reflected in both her publications and grant funding. Hers was one of the first groups that identified circulating biomarkers for tumor hypoxia in HNC, leading to the application of some of these markers in clinical trials, testing hypoxia targeted strategies. 

 

On the clinical side, she has led multicenter phase II and III clinical trials, testing the addition of novel drugs as either radiosensitizer or radioprotector with chemoradiotherapy in HNC. Administratively, she is the Co-Director of the Radiation Biology Program of the Stanford Cancer Institute and the Chair of the Head and Neck Cancer Committee of the NRG Oncology Group, which is part of the NCI supported National Clinical Trial Network (NCTN), running large phase II-III studies for radiation in solid cancers. She serves on the editorial board of several cancer-related journals.

Jeffrey Bradley, MD, Executive Vice-Chair, Department of Radiation Oncology at Emory University School of Medicine, Joins the Cancer Terminator Foundation’s Scientific Advisory Board. 

“The latest advances in the treatment of late-stage cancers using Heavy-Ion Therapy is not currently available in the United States. The Cancer Terminator Foundation is the best solution to this problem. I am proud to work with Dr. Hug, Dr. Frank, and our esteemed Scientific Advisory Board to provide the latest treatments for late-stage cancers. I want to express my high regard to Breakthrough Chronic Care for their support of the Cancer Terminator Foundation.”

Jeffrey D. Bradley, MD

Department of Radiation Oncology, Emory University School of Medicine

Jeffrey D. Bradley, MD, FACR, FASTRO, is executive vice-chair of the Department of Radiation Oncology at Emory University School of Medicine. As a board-certified radiation oncologist, Dr. Bradley specializes in thoracic malignancies with a focus on stereotactic body radiation therapy and proton beam therapy. He is principal investigator of a number of transformational clinical trials for lung cancer patients.

 

Prior to Emory, Dr. Bradley was at Washington University School of Medicine in St. Louis where he was the S. Lee Kling Endowed Professor of Radiation Oncology, clinical director of the Kling Proton Center, and chief of the Radiation Oncology Thoracic Cancer Service. At Barnes Jewish in St Louis, he led the development of the first single-room proton center in the world. Dr. Bradley is Lung Cancer Committee Chair at NRG Oncology, the largest of the four adult National Clinical Trials Network Groups supported by the National Cancer Institute. He was named a fellow of the American Society for Radiation Oncology (ASTRO) in 2017. He served as chair of the lung/sarcoma section of oral boards with the American Board of Radiology for 10 years. He is also a founding member of the Particle Therapy Oncology Group of North America.

 

Dr. Bradley also holds professional memberships with American Society for Radiation Oncology, American Society for Clinical Oncology, and the International Association for the Study of Lung Cancer. Dr. Bradley earned his medical degree at the University of Arkansas for Medical Sciences. He completed his residency at the University of Chicago Medical Center.

Helen Alice Shih, MD, Radiation Oncologist at Harvard Medical School, Joins the Cancer Terminator Foundation’s Scientific Advisory Board. 

“I look forward to working with all the esteemed physicians and scientists on the Scientific Advisory Board of the Cancer Terminator Foundation. This distinguished group of professionals have joined together to bring Heavy-Ion Therapy to the United States. The advanced Heavy-Ion Therapy offers a life-saving cure, but American patients have not had access. Breakthrough Chronic Care’s assistance and support are truly appreciated.”

Helen Alice Shih, MD

Department of Radiation Oncology Massachusetts General Hospital, Boston, MA

Helen Shih, MD, MS, MPH is a practicing radiation oncologist at Massachusetts General Hospital. Prior to MGH, Dr. Shih did her undergraduate education at Brown University as a biology major and medical school education at the University of Pennsylvania where she also earned a Master’s Degree in Cell & Molecular Biology. She completed a transitional year internship at Beaumont Hospital, Royal Oak, MI before radiation oncology residency at MGH. She also has a Master’s in Public Health from the Harvard School of Public Health.

 

Dr. Shih has remained on staff at MGH and is the Director of the Central Nervous System & Eye Services. She specializes in the treatment of patients with brain and eye tumors. She cares for a range of patients with benign to malignant diagnoses and both primary and metastatic diseases. She is an Associate Professor of Radiation Oncology at Harvard Medical School.

 

In her other administrative roles, Dr. Shih is the Medical Director of the MGH Proton Therapy Programs and is the Director of the Proton Therapy Fellowship.

 

Dr. Shih’s research interests are in clinical and translational efforts to better define the role of radiation therapy in the management of her broad spectrum of patients. One sub-specialty interest is proton therapy and improving our understanding and use of this technology. Another interest is in understanding the effects of ionizing radiation on normal tissues, primarily the brain, and how best to reduce the risk of radiation-associated injury. Yet another area of interest is understanding the effects of drug addictions on the brain and developing more effective and curative therapies.

Jiade J. Lu, MD, MBA, Executive President, Shanghai Proton and Heavy-Ion Center, Joins the Cancer Terminator Foundation’s Scientific Advisory Board. 

“Heavy-Ion is the most advanced treatment of certain cancers that are difficult to treat or have been untreatable. Dr. Frank and Dr. Hug are in the vanguard of bringing this life-saving treatment to American cancer patients, where it is not available today. This is the vital role for the Cancer Terminator Foundation. I am delighted to serve on the Scientific Advisory Board. We thank Breakthrough Chronic Care for helping us in our effort to bring the latest cancer treatment to America.” 

Jiade J. Lu, MD, MBA 

Executive President, Shanghai Proton and Heavy-Ion Center

Jiade Lu is a China National Distinguished Expert; Executive Vice President, Shanghai Proton and Heavy Ion Center (SPHIC); Professor of Clinical Oncology, Fudan University School of Medicine, China Dr. Lu obtained his Medical Doctor (M.D.) from the Medical School of the State University of New York at Buffalo, USA, and his M.B.A. from both the University of California, Los Angeles and the National University of Singapore. He completed his residency training in radiation oncology at the University of Miami Jackson Memorial Hospital. After his specialty training, Dr. Lu started his academic career at the Department of Radiation Oncology at the National University Cancer Institute of Singapore (NCIS). In 2010, he was appointed the Head of the Department of Radiation Oncology of the National University Hospital/NCIS. In 2012, he was appointed the Vice-Chairman of Medical Board of the National University Hospital (Research). In February 2014, he accepted the appointment by the Shanghai Municipal Government and started his endeavor as the Executive President of the newly established Shanghai Proton and Heavy Ion Center.

 

Dr. Lu is active in clinical practice as well as academic activity. In addition to his busy clinical and research work in head and neck cancers, he has edited and published 8 oncology texts or reference books, contributed to over 25 book chapters, and close to 100 original articles in international peer-reviewed journals. With help from his colleagues, Dr. Lu started the Journal of Radiation Oncology in 2012. Dr. Lu had served in a number of international publishing and publicly listed corporations as an advisor or independent board member of the board of directors.

Anita Mahajan, MD, Radiation Oncologist at the Mayo Clinic, Joins the Cancer Terminator Foundation’s Scientific Advisory Board.

“Heavy-Ion protons provide effective cancer-killing power, with less collateral damage to adjacent tissues and organs, particularly those that have already been affected by inadvertent radiation during the first cancer treatment. We need to bring Heavy-Ion Therapy to Americans now, and I am happy to join the Cancer Terminator Foundation’s Scientific Advisory Board to help make this happen. I also praise Breakthrough Chronic Care for their support to ensure the future success of this endeavor.”

Anita Mahajan, MD

Radiation Oncologist

Mayo Clinic, Rochester

Dr. Anita Mahajan is a radiation oncologist in Rochester, Minnesota and is a member of the group practice Mayo Clinic. She is also affiliated with Memorial Hermann Texas Medical Center and University Of Texas MD Anderson Cancer Center. She received her medical degree from McGill University in Montreal, Quebec, Canada, where she also completed an internship in internal medicine and a residency in radiation oncology. She went on to Massachusetts General Hospital for a proton fellowship. Dr. Mahajan is certified by the American Board of Radiology. She has 27 years of diverse experience with area of expertise as Radiation Oncology. 

 

She recently received the Castle Connolly Regional Top Doctors award. Castle Connolly is America’s trusted source for the identification of Top Doctors. Their physician-led research team reviews and screens the credentials of tens of thousands of physicians who are nominated by their peers annually, via a nationwide online process, before selecting those physicians who are regionally or nationally among the very best in their medical specialties. 

Jack Scherer, Leading Sales Expert, and Author, Becomes V.P. of ‘Advocate’ Development for Breakthrough Chronic Care.

“The ‘Advocate’ Income Opportunities are groundbreaking. I have been an avid student of sales and marketing strategies and campaigns for 40 years. This is a revolutionary model for patients with chronic illnesses. It eliminates the roadblocks for most people, not a small minority, to be successful. Bravo. Heading nation recruiting, training and creating scalable systems for Mobile, OnSite and Home ‘Advocates’ is inspiring. Focused execution makes dreams come true.”

Jack Scherer

Sales Expert and Author

Jack Scherer is an entrepreneur, author and speaker who has been featured in USA Today, Success Magazine, Advertising Age, AdWeek, Franchising World, Folio, Business Opportunities and other publications. Founder and President of SALESTALENT which helps companies drive new sales through the development of Sales Playbooks, targeted Sales Recruiting, and customized Sales Training programs. The Sales Playbooks deliver a strategic plan for a company containing four integrated parts—structure, process, training and metrics. Jacks clients include IBM, Marriott and Liberty Mutual.

 

Jack has developed proven methods to measure a potential ‘Advocates’ real ‘passion to help DNA.’ His innovative assessment tools have been proven extremely successful. The customized Sales Training programs target the specific needs and solutions for each ‘Advocate’ based upon an innovative audit. (www.salestalent.com). Also, Jack is the owner of a TriMark franchise in Atlanta for 10 years. The Atlanta Franchise was ranked in the top 5% of the franchisees in the network for seven consecutive years.

 

Jack has authored two books: The 21 Laws of Sales Success, a book that describes 21 key principles to drive more sales … a must-read for all sales professionals. And DRIVING PROFIT: How to Start Your Own Business Service and Win, a hands-on guide to help entrepreneurs develop winning businesses.

Our Mission

Breakthrough Chronic Care is a positive lifestyle company committed to significantly improve the physical, emotional and financial health of the 30 million average Americans with a chronic illness and their caregivers. Our movement is dedicated to providing superior chronic disease management and an innovative solution to eliminate up to 100% of a patient's total out-of-pocket medical costs for life. 

Terms of Use | Privacy | © 2019 Breakthrough Chronic Care. All rights reserved.